Συνέπειες εμβολίων

[hellegennes]

Θες να σου βάλω κι άλλα;

Σε ρώτησα αν τα διάβασες, γιατί είμαι σίγουρος ότι δεν ξέρεις τι λένε και αν υποστηρίζουν τον ισχυρισμό σου. Για να σου απαντήσω, όχι, δεν τον υποστηρίζουν. Η μια μελέτη δεν παραθέτει τα δεδομένα ξεχωριστά για τους εμβολιασμένους και τους ανεμβολίαστους και η άλλη δεν έχει καν δεδομένα γι' αυτό, οπότε είναι τελείως άσχετη.

Αντιθέτως, αυτές που παραθέσαμε εμείς είναι καλά σταθμισμένες μελέτες που δείχνουν ότι τα εμβόλια έχουν αυξήσει τα αυτοάνοσα.

Δεν θέλω να μου παραθέσεις πράγματα που δεν έχεις διαβάσει και δεν ξέρεις τι λένε.

Chang et al.2 used the TriNetX network, which maintains the largest global COVID-19 dataset, and identified a study population of over 5.9 million adults from 48 global health care organizations. Propensity score matching was used to generate two cohorts (COVID-19 and non-COVID-19) of 887,455 individuals each to identify the incidence of autoimmune conditions during the study period (1 January 2020 to 31 December 2021). As SARS-CoV-2 vaccination could be a potential confounding factor, only unvaccinated individuals were included in the analyses. The incidence of autoimmune conditions at 6 months follow-up was significantly higher in the COVID-19 cohort than in the non-COVID-19 group.

In addition, an earlier preprint of a retrospective matched cohort analysis using data from the Clinical Practice Research Datalink Aurum database of 458,147 SARS-CoV-2-infected and 1,818,929 uninfected adults across England between 31 January 2020 and 30 June 2021 reported that the incidence of type 1 diabetes mellitus, inflammatory bowel disease and psoriasis are significantly associated with SARS-CoV-2 infection9.

...
H πρώτη μελέτη.
The study included 1,028,721 COVID-19 and 3,168,467 non-COVID individuals. Compared with non-COVID controls, patients with COVID-19 presented an increased risk of developing pernicious anaemia [adjusted Hazard Ratio (aHR): 1.72; 95% Confidence Interval (CI): 1.12–2.64]; spondyloarthritis [aHR: 1.32 (95% CI: 1.03–1.69)]; rheumatoid arthritis [aHR: 1.29 (95% CI: 1.09–1.54)]; other autoimmune arthritis [aHR: 1.43 (95% CI: 1.33–1.54)]; psoriasis [aHR: 1.42 (95% CI: 1.13–1.78)]; pemphigoid [aHR: 2.39 (95% CI: 1.83–3.11)]; Graves' disease [aHR: 1.30 (95% CI: 1.10–1.54)]; anti-phospholipid antibody syndrome [aHR: 2.12 (95% CI: 1.47–3.05)]; immune mediated thrombocytopenia [aHR: 2.1 (95% CI: 1.82–2.43)]; multiple sclerosis [aHR: 2.66 (95% CI: 1.17–6.05)]; vasculitis [aHR: 1.46 (95% CI: 1.04–2.04)]. Among COVID-19 patients, completion of two doses of COVID-19 vaccine shows a decreased risk of pemphigoid, Graves' disease, anti-phospholipid antibody syndrome, immune-mediated thrombocytopenia, systemic lupus erythematosus and other autoimmune arthritis.

Σου το κάνω με ακόμα μεγαλύτερα γράμματα μπας και καταλάβεις τι γράφει.

[Libre arbitre]

Σε ρώτησα αν τα διάβασες, γιατί είμαι σίγουρος ότι δεν ξέρεις τι λένε και αν υποστηρίζουν τον ισχυρισμό σου. Για να σου απαντήσω, όχι, δεν τον υποστηρίζουν. Η μια μελέτη δεν παραθέτει τα δεδομένα ξεχωριστά για τους εμβολιασμένους και τους ανεμβολίαστους και η άλλη δεν έχει καν δεδομένα γι' αυτό, οπότε είναι τελείως άσχετη.

Αντιθέτως, αυτές που παραθέσαμε εμείς είναι καλά σταθμισμένες μελέτες που δείχνουν ότι τα εμβόλια έχουν αυξήσει τα αυτοάνοσα.

Δεν θέλω να μου παραθέσεις πράγματα που δεν έχεις διαβάσει και δεν ξέρεις τι λένε.

Chang et al.2 used the TriNetX network, which maintains the largest global COVID-19 dataset, and identified a study population of over 5.9 million adults from 48 global health care organizations. Propensity score matching was used to generate two cohorts (COVID-19 and non-COVID-19) of 887,455 individuals each to identify the incidence of autoimmune conditions during the study period (1 January 2020 to 31 December 2021). As SARS-CoV-2 vaccination could be a potential confounding factor, only unvaccinated individuals were included in the analyses. The incidence of autoimmune conditions at 6 months follow-up was significantly higher in the COVID-19 cohort than in the non-COVID-19 group.

In addition, an earlier preprint of a retrospective matched cohort analysis using data from the Clinical Practice Research Datalink Aurum database of 458,147 SARS-CoV-2-infected and 1,818,929 uninfected adults across England between 31 January 2020 and 30 June 2021 reported that the incidence of type 1 diabetes mellitus, inflammatory bowel disease and psoriasis are significantly associated with SARS-CoV-2 infection9.

...
H πρώτη μελέτη.
The study included 1,028,721 COVID-19 and 3,168,467 non-COVID individuals. Compared with non-COVID controls, patients with COVID-19 presented an increased risk of developing pernicious anaemia [adjusted Hazard Ratio (aHR): 1.72; 95% Confidence Interval (CI): 1.12–2.64]; spondyloarthritis [aHR: 1.32 (95% CI: 1.03–1.69)]; rheumatoid arthritis [aHR: 1.29 (95% CI: 1.09–1.54)]; other autoimmune arthritis [aHR: 1.43 (95% CI: 1.33–1.54)]; psoriasis [aHR: 1.42 (95% CI: 1.13–1.78)]; pemphigoid [aHR: 2.39 (95% CI: 1.83–3.11)]; Graves' disease [aHR: 1.30 (95% CI: 1.10–1.54)]; anti-phospholipid antibody syndrome [aHR: 2.12 (95% CI: 1.47–3.05)]; immune mediated thrombocytopenia [aHR: 2.1 (95% CI: 1.82–2.43)]; multiple sclerosis [aHR: 2.66 (95% CI: 1.17–6.05)]; vasculitis [aHR: 1.46 (95% CI: 1.04–2.04)]. Among COVID-19 patients, completion of two doses of COVID-19 vaccine shows a decreased risk of pemphigoid, Graves' disease, anti-phospholipid antibody syndrome, immune-mediated thrombocytopenia, systemic lupus erythematosus and other autoimmune arthritis.

Σου το κάνω με ακόμα μεγαλύτερα γράμματα μπας και καταλάβεις τι γράφει.

E, και;

[Libre arbitre]

Chang et al.2 used the TriNetX network, which maintains the largest global COVID-19 dataset, and identified a study population of over 5.9 million adults from 48 global health care organizations. Propensity score matching was used to generate two cohorts (COVID-19 and non-COVID-19) of 887,455 individuals each to identify the incidence of autoimmune conditions during the study period (1 January 2020 to 31 December 2021). As SARS-CoV-2 vaccination could be a potential confounding factor, only unvaccinated individuals were included in the analyses. The incidence of autoimmune conditions at 6 months follow-up was significantly higher in the COVID-19 cohort than in the non-COVID-19 group.

In addition, an earlier preprint of a retrospective matched cohort analysis using data from the Clinical Practice Research Datalink Aurum database of 458,147 SARS-CoV-2-infected and 1,818,929 uninfected adults across England between 31 January 2020 and 30 June 2021 reported that the incidence of type 1 diabetes mellitus, inflammatory bowel disease and psoriasis are significantly associated with SARS-CoV-2 infection9.

...
H πρώτη μελέτη.
The study included 1,028,721 COVID-19 and 3,168,467 non-COVID individuals. Compared with non-COVID controls, patients with COVID-19 presented an increased risk of developing pernicious anaemia [adjusted Hazard Ratio (aHR): 1.72; 95% Confidence Interval (CI): 1.12–2.64]; spondyloarthritis [aHR: 1.32 (95% CI: 1.03–1.69)]; rheumatoid arthritis [aHR: 1.29 (95% CI: 1.09–1.54)]; other autoimmune arthritis [aHR: 1.43 (95% CI: 1.33–1.54)]; psoriasis [aHR: 1.42 (95% CI: 1.13–1.78)]; pemphigoid [aHR: 2.39 (95% CI: 1.83–3.11)]; Graves' disease [aHR: 1.30 (95% CI: 1.10–1.54)]; anti-phospholipid antibody syndrome [aHR: 2.12 (95% CI: 1.47–3.05)]; immune mediated thrombocytopenia [aHR: 2.1 (95% CI: 1.82–2.43)]; multiple sclerosis [aHR: 2.66 (95% CI: 1.17–6.05)]; vasculitis [aHR: 1.46 (95% CI: 1.04–2.04)]. Among COVID-19 patients, completion of two doses of COVID-19 vaccine shows a decreased risk of pemphigoid, Graves' disease, anti-phospholipid antibody syndrome, immune-mediated thrombocytopenia, systemic lupus erythematosus and other autoimmune arthritis.

Σου το κάνω με ακόμα μεγαλύτερα γράμματα μπας και καταλάβεις τι γράφει.

Ναι, έπαθαν τραμπακουλο οι unvaccinated.

[Libre arbitre]

Σου το κάνω με ακόμα μεγαλύτερα γράμματα μπας και καταλάβεις τι γράφει.

Ναι, έπαθαν τραμπακουλο οι unvaccinated.

[Libre arbitre]

.
https://www.everydayhealth.com/coronavi ... nity-debt/

...

[Libre arbitre]

.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837719/

...

[Libre arbitre]

.
https://www.scientificamerican.com/arti ... ovid-risk/

[

...

[Bazoomba]

Ναι Ελληγεννή μου, κάνε εσύ διάλογο με το κουνουπίδι.

[Libre arbitre]

Several new studies reveal that getting multiple COVID vaccine doses provides strong protection against lingering symptoms

3 January 2024

Δυστυχώς αυτά δεν ισχύουν για τους unvaccinated. Έχουν τρελαθεί στα αυτοάνοσα. Τόσο απλά...

[Οργισμένος]

Ναι Ελληγεννή μου, κάνε εσύ διάλογο με το κουνουπίδι.

poly kala sas ta leei

[Libre arbitre]

.
https://www.medrxiv.org/content/10.1101 ... 24300929v1

..

[Libre arbitre]

.
https://www.researchgate.net/publicatio ... opulations

..

[Libre arbitre]

.
https://www.managedhealthcareexecutive. ... cale-study

...

[Libre arbitre]

.
https://www.frontiersin.org/articles/10 ... 42118/full

...

[hellegennes]

Δεν γίνεται να κάνεις διάλογο με κάποιον που βλέπει τίτλους από άρθρα και δεν ξέρει τι λένε.

Δεν στηρίζεις έναν ισχυρισμό έτσι.